Scientists from the University of Birmingham have shown an existing drug may reduce damage after spinal cord injury, by blocking the inflammatory response in the spinal cord.
Their research, published today in Clinical and Translational Medicine, demonstrates that AZD1236, a drug developed by AstraZeneca, can significantly reduce ‘secondary damage’ caused by the body’s response to spinal cord injury (SCI).
Researchers led by Professor Zubair Ahmed, Professor of Neuroscience and lead for the Neuroscience and Ophthalmology Section at The University’s Institute of Inflammation and Ageing, used animal models to demonstrate that AZD1236 can promote significant nerve regeneration, with a dramatic 80% preservation in nerve function following spinal cord compression injury.
Read the full story here: https://www.sciencedaily.com/releases/2022/05/220520073143.htm
Phone:
Address:
11920 Burt St., Suite 145
Omaha, NE 68154
The purpose of this site is to provide basic information, not medical or legal advice. The information is intended to be accurate, but no guarantee is made as to its accuracy, completeness, or being up to date. The owner of this web site is a lawyer. This site may be construed as advertising and promotional materials. Do not use the information on this site as an excuse to avoid seeing a lawyer. If you have a legal problem, you should seek the advice of a competent lawyer. Normally if you talk or write to an attorney, neither you nor the attorney can be forced to share the contents of what was said or written. Some courts do not follow this rule when it comes to e-mail. Also remember that most e-mail is not secure. So be careful about sending any e-mail information about your legal problems. The transmission of an e-mail request for information does not create an attorney-client relationship.